Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic and transcriptional alterations in lung adenocarcinoma in relation to EGFR and KRAS mutation status.

PloS one - 1 Jan 2013

Planck Maria, Edlund Karolina, Botling Johan, Micke Patrick, Isaksson Sofi, Staaf Johan

Abstract excerpt

INTRODUCTION: In lung adenocarcinoma, the mutational spectrum is dominated by EGFR and KRAS mutations. Improved knowledge about genomic and transcriptional alterations in and between mutation-defined subgroups may identify genes involved in disease development or progression. METHODS: Genomic profiles from 457 adenocarcinomas, including 113 EGFR-mutated, 134 KRAS-mutated and 210 EGFR and KRAS-wild type tumors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to ErbB Receptors
Share to EGFR gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to KRAS gene

Share to Genes, ras

Share to Lung Neoplasms

Share to Mutation

Share to Transcription, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 24205279
DOI: 10.1371/journal.pone.0078614
PMCID: PMC3812039

Genes

EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic and transcriptional alterations in lung adenocarcinoma in relation to EGFR and KRAS mutation status.PMID 24205279Read ↗

Genomic Alterations in the RB Pathway Indicate Prognostic Outcomes of Early-Stage Lung Adenocarcinoma.Semantic proximity Read ↗

The transcriptional landscape and mutational profile of lung adenocarcinoma.Semantic proximity Read ↗

Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profilingSemantic proximity Read ↗

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research networkSemantic proximity Read ↗

The Molecular Pathology of Lung Cancer.Semantic proximity Read ↗

Comprehensive molecular profiling of lung adenocarcinoma.Semantic proximity Read ↗

Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.Semantic proximity Read ↗

Landscape of somatic allelic imbalances and copy number alterations in human lung carcinomaSemantic proximity Read ↗

Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation.Semantic proximity Read ↗

Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinomaSemantic proximity Read ↗

Integrated molecular portrait of non-small cell lung cancersSemantic proximity Read ↗

Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.